Novo Nordisk: 2024 Earnings Review

It’s only been a few months since I published my last article on Novo Nordisk ( NVO ) ( OTCPK:NONOF ). I don’t usually post updates this close together, but in this case, I think it’sI am an investor who relies on the fundamental aspects of companies. I enjoy being the owner of the world's best businesses with strong long-term projections. To achieve this, I conduct thorough research on the companies I invest in, placing significant importance on the sector, competitive advantages, and management.Analyst’s ...